FEMY Company Profile and Key Details

FEMY has shown mixed momentum, gaining 14.11% over the past week and -3.47% over the past quarter, though year-to-date performance is up 17.79%. Short-term trend indicators are bullishly aligned (SMA20 6.04%, SMA50 -8.85%, SMA200 -22.46%). The stock’s 14-day RSI is 49.56 (neutral), while the ATR of 0.04 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -68.28% below its high and over 82.03% above its low. Average 10-day trading volume of 385.77 thousand shares is below the 3-month average of 610.16 thousand, indicating normal recent market interest.

Femasys Inc. has 32.58 million shares outstanding. The public float is 27.74 million shares, elevated short interest at 1.52% of float. This equals 363.17 thousand shares. The short ratio is 2.3 days. Institutional investors hold 15.88% of the float. Insiders own 11.3%. Uzialko Edward R holds 127.79 thousand shares, Dyett John has 114.71 thousand shares and Adams John Q JR has 40.00 thousand shares.

Femasys Inc. generated EPS of -$0.72 over the past year. Five-year average earnings growth is 2.49%. Wall Street analysts project EPS growth of 31.35% annually over the next five years. The latest quarter delivered EPS of -$0.10. The next quarter is forecast at -$0.09. Next year's EPS is expected at $45.05. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 6 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $12.00 to $1.50. The high target offers 2690.7% upside. The low target suggests 248.84% downside. The mean target is $7.67. This offers 1683.72% upside. Femasys Inc. earnings surprise history is a mixed track record. The quarter that ended November 14, 2025, missed forecasts by -13.04%. The prior quarter beat by -11.07%. Over the last six quarters, Apple has recorded several small beats. These include 20.0% in November 12, 2024.

Femasys Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.18. This means the shares are trading below this model’s fair value.

Femasys Inc. (NASDAQ:FEMY) closed at $0.44 USD, gaining $0.01 (2.10%) from the previous close of $0.43. The stock is currently mid-range between its 52-week high and low $0.31 and $1.29. With a market capitalization of about $12.90 million, Femasys Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-2.28). Key stats such as the average daily volume over the past year has been around 603.12 thousand shares, volume is running light vs its 52-week average. Headquartered in Suwanee, GA, Femasys Inc. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO Kathy Lee-Sepsick, the company employs approximately 69 people and listed since June 18, 2021. Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States.

Femasys Inc. trades at a P/E ratio of -0.88, slightly below the S&P 500 average, with a price-to-sales ratio of 5.32 and a price-to-book ratio of 2.79 suggesting the stock is closer to book value. The P/FCF stands at -0.52, also above market averages.

Femasys Inc. (NASDAQ:FEMY) shares are up 17.79% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Femasys Inc. trading at a premium to the broader market with a P/E of -0.88. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $10.22, suggesting 2275.64% upside. Our AI forecast model points to short-term weakness (-27.94% over two weeks), a medium-term fall (-30.26% over three months), and a longer-term gain (58.07% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Femasys Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -27.94%, with price expected at $0.31 by April 28, 2026, within a range of $0.28 to $0.34 3-Month Outlook: Projected fall of -30.26%, reaching $0.30 by July 13, 2026, with a range of $0.24 to $0.34. 1-Year Outlook: Projected gain of 58.07%, with price at $0.68 by April 14, 2027, within a range of $0.00 to $0.46.